Skip to content
DilutionScan
Datasea Intelligent Technology Ltd. logo
DTSS$0.609+5.91%

Datasea Intelligent Technology Ltd.

Sector: Services-Prepackaged SoftwareIndustry: Software - InfrastructureCountry: CNExchange: Nasdaq

Mkt Cap$10.19M
Float & O/S
Inst Own

DilutionScan read 11 of Datasea Intelligent Technology Ltd.'s SEC filings and found 1 warrant series, 1 shelf registration and 1 completed offering on file for DTSS. The latest dilution event on file is a registration statement on Sep 8, 2026. Analysis updated Oct 14, 2026.

Signal8 Summary

15d old

DTSS

Going-concern warning, cash just $608K

Business
WeakGoing concern, $4.2M working-capital deficit, cash $608K
Stock risk
High$8.9M micro-cap, Nasdaq deficiency, shares +45.9% YoY

Snapshot

Datasea is a tiny acoustic-tech and AI agent company that shrank sharply this year: FY2026 revenue fell 43% to $40.7M after management exited lower-margin services, and the business lost $2.1M.

What's Happening Right Now

  • : Datasea said service value delivered under its five AI agent customer arrangements reached about $4.0 million as of October 8, 2026, up 264% from mid-September, though the company stresses this reflects services provided, not recognized revenue, against a stated potential annualized volume of up to $89.4 million.
  • : Datasea reported FY2026 revenue of $40.70M (down 43% YoY), narrowed its net loss 57% to about $2.2M, grew gross margin to 10.2%, and turned operating cash flow positive at roughly $2.0M, while also disclosing a second 180-day Nasdaq compliance period running to March 22, 2027.
  • : Datasea's FY2026 20-F disclosed an auditor going-concern warning, cash of just $0.61M, a $4.20M working-capital deficit, and a $46.71M accumulated deficit, even as revenue fell 43% to $40.7M amid a deliberate pivot away from low-margin 5G services.
  • : Datasea received a 180-day extension to March 22, 2027 to regain Nasdaq's $1.00 minimum bid price compliance, with the company signaling it may use a reverse stock split to cure the deficiency.
  • : Registered $150.00M of securities for sale on Form F-3.
  • : Datasea's NeuroVibe NV-02/NV-03 biofeedback devices completed FDA establishment registration and device listing as Class II 510(k)-exempt devices, a regulatory step short of full FDA approval.
  • : Closed an offering. Proceeds are not disclosed in the filings reviewed.
  • : Issued warrants over 513K shares.

Raise routes on file: effective shelf · latest dilution event 56 days ago

Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need

AI dilution summary

The dominant contractual driver and its mechanism, then each further driver ranked.

Latest dilution event

Sep 8, 2026 · Registration

How we read filings

Every warrant, convertible, ATM and shelf, cited to the filing

A free account reads 3 tickers a day in full

Get Pro · every ticker

$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)

Share count and cash history

Shares outstanding, potential dilution and cash over time

Warrants · 1

What is this?

Exercise price, shares and dates with Pro

July 2024 Registered Direct Pre-Funded Warrants ( exercise price)

Issued 2024

Outstanding

Shares Underlying

Exercise Price

Outstanding
Type
Anti-Dilution
Cashless Exercise
Expiration
Filing link and full terms

Shelf · 1

What is this?

Capacity, dates and baby-shelf status with Pro

F-3 shelf registration

Issued 2026

Active

Total capacity

Remaining

Filed
Effective
Expires
Baby shelf
Filing link and full terms

Offerings · 1

What is this?

Proceeds, price, shares and agent with Pro

Offering

Issued 2026

Gross proceeds

Price per share

Shares issued
Warrant coverage
Placement agent
Filing link and full terms

Know who's about to sell into your DTSS trade

Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.

Get Pro · every ticker

$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)

DilutionScan ProEvery instrument in full · $59/mo